Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism.

Authors:
Peterson SM; Juliana CA; Hu CF; Chai J; Holliday C and 11 more

Journal:
Diabetes

Publication Year: 2023

DOI:
10.2337/db22-1039

PMCID:
PMC10450825

PMID:
37358194

Journal Information

Full Title: Diabetes

Abbreviation: Diabetes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Duality of Interest. S.M.P., C.F.H., C.H., A.G.L.H., Z.C., L.W., Z.H., N.H., R.S., F.A., T.Z.Y., and A.K.S. are employees of and own stock in Twist Bioscience. Twist Bioscience provided funding for this study. No other potential conflicts of interest relevant to this article were reported."

Evidence found in paper:

"Duality of Interest. S.M.P., C.F.H., C.H., A.G.L.H., Z.C., L.W., Z.H., N.H., R.S., F.A., T.Z.Y., and A.K.S. are employees of and own stock in Twist Bioscience. Twist Bioscience provided funding for this study. No other potential conflicts of interest relevant to this article were reported."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025